A Case of IgG4-related Sclerosing Cholangitis Mimicking an Intrahepatic Cholangiocellular Carcinoma.

12:09 EDT 21st September 2014 | BioPortfolio

Summary of "A Case of IgG4-related Sclerosing Cholangitis Mimicking an Intrahepatic Cholangiocellular Carcinoma."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Japanese journal of clinical oncology
ISSN: 1465-3621
Pages: 153


PubMed Articles [19313 Associated PubMed Articles listed on BioPortfolio]

IgG4-Related Disease in the Abdomen: A Great Mimicker.

IgG4-related disease is a systemic disorder that can involve various abdominal organs. Abdominal manifestations include autoimmune pancreatitis, sclerosing cholangitis, gallbladder pseudotumours, mult...

Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity?

This is a review of the characteristic findings of inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC) and their usefulness in the diagnosis of sclerosing cholangitis...

Serum IgG4 and IgG1 for Distinguishing IgG4-Associated Cholangitis from Primary Sclerosing Cholangitis.

The recent addition of IgG4-associated cholangitis (IAC), also called IgG4-related sclerosing cholangitis (IRSC) to the spectrum of chronic cholangiopathies has created the clinical need for reliable ...

Diagnosis and Classification of Autoimmune Pancreatitis.

Recent studies suggested the existence of two subtypes of autoimmune pancreatitis (AIP): type 1 related with IgG4 as the pancreatic manifestation of IgG4-related disease (IgG4-RD), and type 2 related ...

Intrapancreatic Biliary Stricture in Autoimmune Pancreatitis Should Not Be Included in IgG4-Related Sclerosing Cholangitis.

Clinical Trials [1482 Associated Clinical Trials listed on BioPortfolio]

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

OBJECTIVES: I. Assess the safety and effectiveness of budesonide in patients with primary sclerosing cholangitis or primary biliary cirrhosis experiencing a suboptimal response to ursode...

Trial of High-dose Urso in Primary Sclerosing Cholangitis

This is a multicenter, randomized, controlled trial of high dose ursodiol versus placebo for patients with primary sclerosing cholangitis (PSC). The average duration of follow-up will be ...

Pilot Study of Fenofibrate in Primary Sclerosing Cholangitis (PSC)

The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).

The Value of CT Cholangiography in Primary Sclerosing Cholangitis

The reason for this study is to see if a new radiologic technique called computerized tomographic cholangiography (CT cholangiography) could be helpful to demonstrate the bile ducts featur...

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis

OBJECTIVES: I. Evaluate the effects of cladribine (2-chlorodeoxyadenosine; 2-CdA) on biochemical, radiologic, and histologic parameters in patients with early stage primary sclerosing ...

Medical and Biotech [MESH] Definitions

Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.

Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.

Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

The use of one's knowledge in a particular profession. It includes, in the case of the field of biomedicine, professional activities related to health care and the actual performance of the duties related to the provision of health care.

FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.

Search BioPortfolio: